Oxolamine (hydrochloride)
Oxolamine hydrochloride (SKF-9976 hydrochloride) is an orally active antitussive. Oxolamine hydrochloride can inhibit CYP2B1/2. Oxolamine hydrochloride has anti-inflammatory effects on the respiratory organs of guinea pigs. Oxolamine hydrochloride increases the AUC of Warfarin and prolongs its terminal half-life. Oxolamine hydrochloride can be used in respiratory disease research[1][2][3][4].
Product Specifications
CAS Number
1219-20-1
UNSPSC
12352005
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/oxolamine-hydrochloride.html
Smiles
CCN(CC)CCC1=NC(C2=CC=CC=C2)=NO1.Cl
Molecular Formula
C14H20ClN3O
Molecular Weight
281.78
References & Citations
[1]Kirilmaz L, et, al. Sustained-release dosage form of oxolamine citrate: preparation and release kinetics. J Microencapsul. Apr-Jun 1992;9 (2) :167-72.|[2]GIUDICI G, et, al. [On the anti-inflammatory action of oxolamine citrate]. Minerva Med. 1961 Oct 31;52:3752-5.|[3]Zhu X, et al. Gender difference in the pharmacokinetic interaction between oral warfarin and oxolamine in rats: inhibition of CYP2B1 by oxolamine in male rats. Biopharm Drug Dispos. 2007 Apr;28 (3) :125-33.|[4]Dahlgren S, et al. The effect of oxolamine citrate on experimentally produced inflammation in the respiratory organs. Acta Pharmacol Toxicol (Copenh) . 1966;24 (2) :286-96.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP13678PU-N 400 µL
BCKDH kinase (BCKDK) (C-term) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
